ACRS · Aclaris Therapeutics, Inc. · Exempt Offerings
$3.76
-0.03 (-0.75%)
At close · Oct 28
Return incl. dividend (before tax)
Q1 2024 earnings call transcript
Market Cap
$582.91M
Shares
147.20M
Volume · Oct 28
3.88M
Avg daily vol (3M)
2.85M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1557746
CUSIP
00461U105
13F (30d)
26 filings
21 filers
Visit website
Investor relations